PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012
Rukwa regional medical office (RMO) will coordinate and provide facility-based care services in all facilities in the region where care and treatment programs are set up. This will include the intergration of positive prevention services supporting nutritional assessment and counseling. Rukwa RMO will support improving linkages of facilities with other services including home based care in Rukwa region.
Maintain quality HIV services at existing sites and scaling up to cover private hospitals and previously underserved areas. This will be accomplished through regular supportive supervision, clinical and nutrition mentoring, patient monitoring, and ensuring uninterrupted supply of drugs and reagents through central procurement mechanism,Capacity building to local partners in financial accountability, technical support, program oversight and M&E. Partner works in four district and currently covers 5,817 patients on treatment. Many efforts are taken in TB/HIV and prevention program including PITC and PMTCT, therefore, we expect an increase in the number of new HIV positive patients refered to existing care and treatment clinic. Additional funds will be used to support passive growth of approximately 400 new patients coming to existing Care and treament clinics managed by Rukwa.
These funds are proposed for the following activities: Scale up cotrimoxazole (CTX) prophylaxis for HIV-exposed and infected children; provide nutrition assessment, counseling and support; provide prevention, diagnosis and management of tuberculosis and other opportunistic infections (OI's); provide palliative care and psychosocial support. The funds will be used to improve linkages to Community Based Care including: under 5 child survival interventions and community HIV supported services. These activities will be achieved through training and on-site mentorship, establishment of coordinating committees with community-based organizations, advocacy and community mobilization. These activities will take place in Rukwa.
These funds are proposed for the following activities: Implement updated WHO treatment guidelines to improve access to pediatric ART, including treatment of all HIV infected children <24 months;enhance the identification and diagnosis of HIV for infants and children through EID, PITC in in-patient and out-patient settings, immunization, OVC, and TB/HIV clinics; improve follow-up services for HIV-exposed infants and children and track and retain children in care and treatment; monitor response and adherence to treatment. These activities will be achieved through training, on-site mentorship, advocacy, community mobilization, and updating of tools for tracking and retention. These activities will take place in Rukwa with the aim of enrolling 415 new children on ART. $100,000 in additional funds will be added for strengthening referrals and linkages due to a high ANC prevalence.
Continuation of MC support in Rukwa
Rukwa has 5 districts and an HIV prevalence of 7.2%. The PMTCT site coverage is 65%. The IP will support scale-up of PMTCT services to cover 80% of pregnant women with counseling and testing. For those found HIV negative, retesting will be considered in late pregnancy, labour and delivery or during postpartum period (and document sero-conversion). Women found HIV positive will be provided with ARV prophylaxis (75% and 85% of HIV positive pregnant women in 2011 and 2012 respectively) in three regions. The IP will support scale-up of EID to 65% of HIV exposed infants through RCH clinics.
Maintain services related to implementation of the Three I's. It is estimated that around 20% of new patients enrolling into ART would present with signs and symptoms of advanced HIV disease and diagnosing TB among this group remains difficult as the routine diagnostic tests (AFB smear microscopy and/or chest X ray) are neither very sensitive nor very specific and undiagnosed TB remains a major cause of mortality in this group. To enhance TB diagnosis in this group, there is a high need of investing in sophisticated TB diagnostic tests e.g. Liquid culture and Line Probe Assays. To increase access to this service, Rukwa RMO will coordinate transportation of sputum and/or blood samples to Mbeya referral Hospital for Liquid culture and LPAs. Rukwa RMO will participate in the pilot and subsequent scale up of Three I's. Service will continue being provided in Rukwa region
